ASCEnD is an open label randomised controlled trial investigating the clinical and cost-effectiveness of an aripiprazole and sertraline combination compared to quetiapine for the treatment of bipolar depression. The study is funded by the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) panel and led from Newcastle. The study is largely conducted remotely, with participants completing assessment scales on-line and being remotely monitored by RAs based in Newcastle.
Main duties of the job
Under the supervision, the post-holder will:
MNCJobs.co.uk will not be responsible for any payment made to a third-party. All Terms of Use are applicable.